1Simpson B J, Hammacher A, Smith Dk, et al. Interleukin-6: structure-function relationships, Protein Sci 1997; 6 ( 5 ) : 929 - 55.
2Zheng SX, Vrindts Y, Lopez M, et al. Increase in cytokine production(IL-1 bata,IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas 1997; 26:63 -71.
3Tsukamoto K, Yoshida H, Watanabe S, et al. Association of radial bone mineral density with CA repeat polymorphism at the interleukin-6 locus in postmenopausal Japanese women,J Hum Geaet 1999; 44(3): 148 -51.
4Kania Din, Binkley N, Checovich M, et al. Elevated plasma level of interleikin-6 in postmenopausal women do not correlate with bone density, J Am Geriatr Soc 1995:43:236-9.
5Takacs I, Koller DL, Peacock M, et al. Sib pair linkade and association studies between bone mineral density and the interleukin-6 gene locus, Bone 2000; 27(1): 169-73.
6Mundy GR, Boyce BF, Yoneda T, et al. Cytokine and bone remodeling. In:Marcus R, Feldman D, KelseyJ(eds) . Osteoporosis. Caniforia: Academic Press 1996:301 - 13.
7Sporeno E, Savino R, Ciapponi L, et al. Human interleukin-6 receptor superantagonists with high potence and wide spectrum on multiple myeloma cells. Blood 1996: 87(11): 4510-9.
8Girasole G. 17β-estradiol-inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antisteoporotic effect of estrogens. J Clin Invest 1992; 89:883 -6.
9Manolagas SC. The role of IL-6 type cytokine and their receptor in bone. Ann N Y Acad Sci 1998; 1:194 -204.
10Koka S, Petro TM, Reinhardt RA. Estrogen inhibits interleukin-lbeta-induced interleukin-6 production by human osteoblast-like cells.J Interferon Cytokine Res 1998; 18(7): 479-83.
10Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factor alpha stimulates osteoblast differentiation by a mechanism independent of the ODF/RANKL RANK interaction [J] . J Exped Med, 2000, 191 :275.
